Form 4 for CRVL CORVEL CORP
Accepted 2026-01-07 00:00:00 ET · period of report 2026-01-05 · accession 0001641248-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-01-07 | 2026-01-05 | CRVL | Combs Michael G | CEO, Pres | F - Tax | $68.14 | -24.0K | 50.9K | -32% | -$1.63M |
| DM | 2026-01-07 | 2026-01-05 | CRVL | Combs Michael G | CEO, Pres | M - OptEx | $51.69 | +28.4K | 72.1K | +65% | +$1.47M |
| DM | 2026-01-07 | 2026-01-05 | CRVL | Combs Michael G | CEO, Pres | M - OptEx | $68.14 | -28.4K | 0 | -100% | -$1.94M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-05 | F | D | 79 | $68.14 | 48,773 | D | — | — | |
| 2 | Common | Common Stock | 2026-01-05 | F | D | 292 | $68.14 | 48,852 | D | — | — | |
| 3 | Common | Common Stock | 2026-01-05 | M | A | 501 | $39.83 | 49,144 | D | — | — | |
| 4 | Common | Common Stock | 2026-01-05 | F | D | 29 | $68.14 | 48,643 | D | — | — | |
| 5 | Common | Common Stock | 2026-01-05 | F | D | 78 | $68.14 | 48,672 | D | — | — | |
| 6 | Common | Common Stock | 2026-01-05 | M | A | 156 | $34.44 | 48,750 | D | — | — | |
| 7 | Common | Common Stock | 2026-01-05 | F | D | 2,306 | $68.14 | 48,594 | D | — | — | |
| 8 | Common | Common Stock | 2026-01-05 | M | A | 27,750 | $52.00 | 72,075 | D | — | — | |
| 9 | Common | Common Stock | 2026-01-05 | F | D | 21,175 | $68.14 | 50,900 | D | — | — | |
| 10 | Derivative | Non-Qualified Stock Option (right to buy) | 2026-01-05 | M | D | 156 | $68.14 | 0 | D | $34.44 · — to 2026-02-04 | 156 Common Stock | (F2) Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. |
| 11 | Derivative | Non-Qualified Stock Option (right to buy) | 2026-01-05 | M | D | 27,750 | $68.14 | 22,871 | D | $52.00 · — to 2027-11-03 | 27,750 Common Stock | (F2) Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. |
| 12 | Derivative | Non-Qualified Stock Option (right to buy) | 2026-01-05 | M | D | 501 | $68.14 | 0 | D | $39.83 · — to 2026-05-06 | 501 Common Stock | (F2) Exercisable as to 25% of shares one year following grant date with the remaining shares exercisable in 36 equal monthly installments thereafter. |